Have baby, will travel

Despite huge medical advances over recent years, national policy on funding and access to fertility treatment varies widely from country to country. As regulation...

Safety dominates debate at Private Healthcare Summit

Key stakeholders from across independent healthcare gathered in London this week for the Private Healthcare Summit, which was set against a backdrop of increased...

IVF – fertile ground for consolidation?

Despite recent private equity interest, IVF and fertility treatment remains a highly fragmented market but that could be about to change. Dr Leonid Shapiro,...

A fair deal for would-be parents

English clinical commissioning groups (CCGs) are continuing to reduce the number of IVF treatment cycles they fund. How is this affecting demand for self-funded...

IVF – a boom ahead?

The UK fertility market is set to grow by 3% a year, and with rates per female population below many of its European neighbours...

Practice purchases and negligence – can the risk be alleviated?

Hazel Philips, specialist healthcare lawyer at law firm Royds Withy King, looks at the actions corporate dentistry groups can take to mitigate risk when buying...

Revitalising the sector with outcomes analytics

Regulation is pushing the independent healthcare sector to collect and publish more data on outcomes than ever before but the use of outcomes data...

Paying for prevention

With 30% of five-year-olds in deprived areas suffering some form of tooth decay, is it time for a new dental contract that focuses more...

Investor interest in healthcare real estate accelerating

Investor activity in healthcare real estate is accelerating despite continued yield compression, as the sector outperforms other real estate and investment options, delegates at...

Healthcare real estate from the fringes to the core

Historically, healthcare has been a niche area of the real estate investment market in the UK but Tom Morgan, senior director, healthcare at CBRE,...